Literature DB >> 33302367

The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors.

Despoina Pouloudi1, Aristoteles Sotiriadis1, Margarita Theodorakidou1, Panagiotis Sarantis2, Alexandros Pergaris1, Michalis V Karamouzis2, Stamatios Theocharis1.   

Abstract

Salivary gland carcinomas (SGCs) represent a group of rare tumors, with complete surgical resection being the main treatment option. Therapeutic armory for cases of locally aggressive, recurrent, and/or metastatic SGCs, though, remains poor since they exhibit high rates of resistance to systematic therapy. Angiogenesis is considered one of the contemporary hallmarks of cancer and anti-angiogenic factors have already been approved for the treatment of several cancer types. This review aims to summarize, in a histotype-specific manner, the most current available data on the angiogenic factors implicated in SGC angiogenesis, in order to highlight the differences between the most common SGC histotypes and the factors that may have a potential role as therapeutic targets.

Entities:  

Keywords:  angiogenesis; angiogenic factors; anti-angiogenic factors; histotypes; salivary gland tumor; therapy

Year:  2020        PMID: 33302367      PMCID: PMC7762607          DOI: 10.3390/ijms21249335

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  66 in total

1.  A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.

Authors:  L D Locati; F Perrone; B Cortelazzi; C Bergamini; P Bossi; E Civelli; C Morosi; S Lo Vullo; M Imbimbo; P Quattrone; G P Dagrada; R Granata; C Resteghini; A Mirabile; S Alfieri; E Orlandi; L Mariani; G Saibene; S Pilotti; L Licitra
Journal:  Eur J Cancer       Date:  2016-11-05       Impact factor: 9.162

2.  Caveolin-1 expression enhances endothelial capillary tubule formation.

Authors:  Jun Liu; Xiao Bo Wang; David S Park; Michael P Lisanti
Journal:  J Biol Chem       Date:  2001-12-17       Impact factor: 5.157

3.  A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC.

Authors:  N G Chau; S J Hotte; E X Chen; S F Chin; S Turner; L Wang; L L Siu
Journal:  Ann Oncol       Date:  2011-11-11       Impact factor: 32.976

4.  Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results.

Authors:  Hope S Rugo; Roy S Herbst; Glenn Liu; John W Park; Merrill S Kies; Heidi M Steinfeldt; Yazdi K Pithavala; Steven D Reich; James L Freddo; George Wilding
Journal:  J Clin Oncol       Date:  2005-07-18       Impact factor: 44.544

5.  NF-kappaB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro.

Authors:  Jiali Zhang; Bin Peng
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

6.  Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.

Authors:  Junya Ono; Yasuo Okada
Journal:  Odontology       Date:  2017-12-14       Impact factor: 2.634

7.  Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma.

Authors:  Wei-Ming Wang; Zhi-Li Zhao; Wen-Feng Zhang; Yi-Fang Zhao; Lu Zhang; Zhi-Jun Sun
Journal:  Mol Med Rep       Date:  2015-05-22       Impact factor: 2.952

Review 8.  A Review of Selected Factors of Salivary Gland Tumour Formation and Malignant Transformation.

Authors:  Pawel Sowa; Karolina Goroszkiewicz; Joanna Szydelko; Joanna Chechlinska; Katarzyna Pluta; Wojciech Domka; Maciej Misiolek; Wojciech Scierski
Journal:  Biomed Res Int       Date:  2018-08-01       Impact factor: 3.411

Review 9.  Systemic therapy for recurrent or metastatic salivary gland malignancies.

Authors:  Ashish V Chintakuntlawar; Scott H Okuno; Katharine A Price
Journal:  Cancers Head Neck       Date:  2016-09-01

10.  Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.

Authors:  Sungweon Choi; Daisuke Sano; Melvina Cheung; Mei Zhao; Samar A Jasser; Anderson J Ryan; Li Mao; Wan-Tao Chen; Adel K El-Naggar; Jeffrey N Myers
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

View more
  1 in total

Review 1.  A Synopsis of Signaling Crosstalk of Pericytes and Endothelial Cells in Salivary Gland.

Authors:  Ioana Cucu; Mihnea Ioan Nicolescu
Journal:  Dent J (Basel)       Date:  2021-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.